Evidence map›Paper›PMID 22038516›Full record

ArticleDiabetologia2012

cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets.

S L Subramanian, R L Hull, S Zraika, K Aston-Mourney, J Udayasankar, S E Kahn

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Protein Kinases Signaling in Pancreatic Beta-cells Death and Type 2 Diabetes.Advances in experimental medicine and biology · 2021
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. RNA-seq-based identification of Star upregulation by islet amyloid formation.Protein engineering, design & selection : PEDS · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

S L SubramanianDivision of Metabolism, Endocrinology, and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, 1660 South Columbian Way, Seattle, WA 98108, USA.
R L Hull
S Zraika
K Aston-Mourney
J Udayasankar
S E Kahn
University of Washington · USVA Puget Sound Health Care System · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
Mechanisms of Islet AmyloidogenesisR01DK075998 · NIDDK · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI KAHN, STEVEN EMANUEL · 2008 to 2011
$1.2M
The role of neprilysin in pancreatic beta-cell dysfunction and deathR00DK080945 · NIDDK · UNIVERSITY OF WASHINGTON · PI ZRAIKA, SAKENEH · 2011 to 2013
$737k
Role of perlecan in islet amyloid formationK01DK074404 · NIDDK · UNIVERSITY OF WASHINGTON · PI HULL-MEICHLE, REBECCA LUCY · 2006 to 2010
$596k
The role of neprilysin in pancreatic beta-cell dysfunction and deathK99DK080945 · NIDDK · UNIVERSITY OF WASHINGTON · PI ZRAIKA, SAKENEH · 2009 to 2010
$180k
NIDDK NIH HHS DK-007247NIDDK NIH HHS DK-017047NIDDK NIH HHS DK-074404NIDDK NIH HHS DK-075998NIDDK NIH HHS DK-080945NIDDK NIH HHS K01 DK074404NIDDK NIH HHS K99 DK080945NIDDK NIH HHS P30 DK017047NIDDK NIH HHS R00 DK080945NIDDK NIH HHS R01 DK075998NIDDK NIH HHS T32 DK007247
6 · The paper itself

Abstract

aims/hypothesisAggregation of human islet amyloid polypeptide (hIAPP) as islet amyloid is associated with increased beta cell apoptosis and reduced beta cell mass in type 2 diabetes. Islet amyloid formation induces oxidative stress, which contributes to beta cell apoptosis. The cJUN N-terminal kinase (JNK) pathway is a critical mediator of beta cell apoptosis in response to stress stimuli including oxidative stress and exogenous application of hIAPP. We determined whether amyloid formation by endogenous hIAPP mediates beta cell apoptosis through JNK activation and downstream signalling pathways.

methodshIAPP transgenic and non-transgenic mouse islets were cultured for up to 144 h in 16.7 mmol/l glucose to induce islet amyloid in the presence or absence of the amyloid inhibitor Congo Red or a cell-permeable JNK inhibitor. Amyloid, beta cell apoptosis, JNK signalling and activation of downstream targets in the intrinsic and extrinsic apoptotic pathways were measured.

resultsJNK activation occurred with islet amyloid formation in hIAPP transgenic islets after 48 and 144 h in culture. Neither high glucose nor the hIAPP transgene alone was sufficient to activate JNK independent of islet amyloid. Inhibition of islet amyloid formation with Congo Red reduced beta cell apoptosis and partially decreased JNK activation. JNK inhibitor treatment reduced beta cell apoptosis without affecting islet amyloid. Islet amyloid increased mRNA levels of markers of the extrinsic (Fas, Fadd) and intrinsic (Bim [also known as Bcl2l11]) apoptotic pathways, caspase 3 and the anti-apoptotic molecule Bclxl (also known as Bcl2l1) in a JNK-dependent manner. CONCLUSIONS/

interpretationIslet amyloid formation induces JNK activation, which upregulates predominantly pro-apoptotic signals in both extrinsic and intrinsic pathways, resulting in beta cell apoptosis.

Indexed as

ApoptosisMAP Kinase Signaling SystemAmyloidAnimalsApoptosis Regulatory ProteinsEnzyme ActivationGene Expression RegulationHemizygoteHumansInsulin-Secreting CellsIslet Amyloid PolypeptideIslets of LangerhansJNK Mitogen-Activated Protein KinasesMaleMiceMice, TransgenicAmyloidApoptosis Regulatory ProteinsIslet Amyloid PolypeptideJNK Mitogen-Activated Protein KinasesProtein Kinase InhibitorsRNA, Messenger

Identifiers

PMID22038516
PMCPMC3249975
OpenAlexW2000460252

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.